Novel immunotherapy strategies for multiple myeloma and other haematological malignancies

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Scopus)


Since mid nineties, research at the Hemato-Oncology section of the dept. of Clinical Chemistry and Hematology in UMC Utrecht is focused on development and subsequent clinical translation of novel immunotherapy strategies for hematological malignancies, in particular for multiple myeloma (MM). These research activities are highly integrated with the clinical profile of the dept of Hematology. In this short overview, we will provide the specific goals and the current status of this research.

Original languageEnglish
Pages (from-to)38-41
Number of pages4
JournalNederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde
Issue number1
Publication statusPublished - 1 Jan 2012

Cite this